Compugen CGEN
NASDAQ CGEN
$2.59 +0.03 (+1.37%)
As of: Sep 4, 2026 · 1:31 PM EDT

Compugen (CGEN) Operating Income (2009 - 2026)

Compugen (CGEN) posted quarterly Operating Income of $9.0 million for Q1 2026, up 7.41% year-over-year from $8.4 million in Q1 2025, and down 83.91% on a QoQ basis from $56.0 million in Q4 2025.

Analysis

Compugen (CGEN) Operating Income (2009 - 2026) Analysis & Trends

Compugen has reported Operating Income for 18 years, with the latest figure at $9.0 million in Q1 2026.

  • Operating Income for Q1 2026 came in at $9.0 million, up 7.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $31.9 million (up 313.16% YoY), and the FY2025 annual result was $31.3 million, up 310.37% from the prior year.
  • Operating Income eased to $9.0 million in Q1 2026, from $56.0 million in the prior quarter.
  • Over five years, Operating Income peaked at $56.0 million in Q4 2025 and troughed at -$30.5 million in Q2 2023.
  • A 5-year average of -$218733.3 and a median of -$3.5 million in 2022 frame the typical range for Operating Income.
  • The largest YoY upside for Operating Income was 848.94% in 2025 against a maximum downside of 275.56% in 2025.
  • A 5-year view of Operating Income shows it stood at -$3.5 million in 2022, then surged by 609.61% to $18.0 million in 2023, then tumbled by 141.61% to -$7.5 million in 2024, then surged by 848.94% to $56.0 million in 2025, then slumped by 83.91% to $9.0 million in 2026.
  • Per Business Quant data, the three most recent Operating Income figures were $9.0 million in Q1 2026, $56.0 million in Q4 2025, and -$7.9 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 493.00 Mn
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - -505.13 Mn
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 133.12 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -1.55 Mn
10 Compugen 241.97 Mn 156.35 Mn -92,000.00 -26.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -26.87 Mn
Mar 31, 2026 9.02 Mn
Dec 31, 2025 56.04 Mn
Sep 30, 2025 -7.89 Mn
Jun 30, 2025 -25.22 Mn
Mar 31, 2025 8.40 Mn
Dec 31, 2024 -7.48 Mn
Sep 30, 2024 4.50 Mn
Jun 30, 2024 -20.40 Mn
Mar 31, 2024 8.49 Mn
Dec 31, 2023 17.98 Mn
Sep 30, 2023 -10.63 Mn
Jun 30, 2023 -30.48 Mn
Mar 31, 2023 10.13 Mn
Dec 31, 2022 -3.53 Mn
Sep 30, 2022 -12.21 Mn
Dec 31, 2021 -8.78 Mn
Sep 30, 2021 -6.33 Mn
Mar 31, 2021 -10.26 Mn
Dec 31, 2020 -9.09 Mn